Shares of DocGo Inc. (NASDAQ:DCGO – Get Rating) gapped up before the market opened on Tuesday following a stronger than expected earnings report. The stock had previously closed at $8.70, but opened at $9.50. DocGo shares last traded at $7.72, with a volume of 531,336 shares.
The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.06. DocGo had a return on equity of 16.14% and a net margin of 10.34%. The firm had revenue of $108.79 million during the quarter, compared to analyst estimates of $104.13 million. During the same period last year, the company posted $0.17 EPS.
Hedge Funds Weigh In On DocGo
Several institutional investors have recently bought and sold shares of the company. Altshuler Shaham Ltd purchased a new stake in DocGo during the third quarter valued at about $28,000. Federated Hermes Inc. bought a new position in shares of DocGo during the third quarter valued at approximately $29,000. Royal Bank of Canada increased its stake in shares of DocGo by 226.3% during the first quarter. Royal Bank of Canada now owns 3,263 shares of the company’s stock valued at $30,000 after purchasing an additional 2,263 shares in the last quarter. Point72 Hong Kong Ltd purchased a new stake in shares of DocGo during the third quarter valued at approximately $39,000. Finally, Wells Fargo & Company MN boosted its holdings in DocGo by 320.1% in the fourth quarter. Wells Fargo & Company MN now owns 6,192 shares of the company’s stock worth $44,000 after purchasing an additional 4,718 shares during the last quarter. Hedge funds and other institutional investors own 36.88% of the company’s stock.
DocGo Stock Down 3.2 %
DocGo Company Profile
DocGo, Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Recommended Stories
- Get a free copy of the StockNews.com research report on DocGo (DCGO)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts DefendĀ
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.